Advanced Search
Contact | Corporate | Help

Avastin and Erlotinib as First Line Consolidation Chemotherapy After Carboplatin, Paclitaxel, and Avastin (CTA) Induction Therapy for Advanced Ovarian, Fallopian Tube, and Primary Peritoneal Cancer, and Papillary Serous Mullerian Tumors

Sponsors:
  • Dana-Farber Cancer Institute
  • Genentech
  • Beth Israel Deaconess Medical Center
  • Brigham and Women's Hospital
  • Massachusetts General Hospital
Phases:
  • Phase II
IndicationsAcronym:
  • Ovarian Cancer
  • Fallopian Tube Cancer
  • Primary Peritoneal Cancer
  • Papillary Serous Mullerian Cancer
Age Groups:
  • Adult
  • Senior
Gender:
Female
Names:
  • Drug: Avastin
  • Drug: erlotinib
  • Drug: paclitaxel
  • Drug: carboplatin
Enrollment:
60

Additional information about NCT00520013.


SourceSolution © 2008-2012